Amplification of the PAK4 gene and dysregulated activation of the PAK4 protein are commonly observed in ovarian cancer, breast carcinoma, and pancreatic carcinoma (Ha et al., 2015; Won et al., 2019). This evidence concerns the gene PAK4 and ovarian cancer.